You may finally have an answer to what’s been causing all that congestion. But you probably still have lingering questions about this chronic nasal condition. Even after you’ve spoken to your doctor, ...
Nasal polyp development, treatment, and recurrence were topics up for discussion in this year’s most popular nasal polyps–related content. Nasal polyp development, treatment, and recurrence, as well ...
Dupixent can be used for several conditions, once of which is treating ongoing nasal and sinus inflammation due to nasal polyps. It can be used for both adults and certain children. Dupixent is an ...
Nasal polyps are soft growths that can develop in your nose as a result of long-term swelling — from colds, allergies, and other conditions — in your nasal passages. They are more common in people who ...
Addition of the monoclonal antibody stapokibart significantly improved nasal polyps and nasal congestion in adults with uncontrolled chronic rhinosinusitis with nasal polyps, based on new data from ...
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 ...
If these treatments are insufficient, polyps can be surgically removed via sinus surgery. After the procedure, chronic rhinosinusitis with nasal polyps is generally manageable, but a small percentage ...
Clinicians have a new line of weapons in their arsenal to treat recurring nasal polyps. Over the past year several new monoclonal antibody-based biologic drugs have been approved to treat the ...
Experts share their thoughts on the link between these respiratory conditions and what it means for treatment. Nasal polyps are small, noncancerous growths that develop inside the nasal canal. They ...
Please provide your email address to receive an email when new articles are posted on . Nasal polyp and congestion scores dropped more with stapokibart vs. placebo. Overall nasal symptoms, sense of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results